Feedback and photos
Let us know how you experienced this conference and tell us about your ideas for future activities. It only takes a minute.
Your feedback is highly appreciated !
View photos of the event.
Programme
09:00
Registrations & welcome coffee
09:45
Welcome by Fran Van Heuverswyn, Flanders Vaccine
Morning Session: The importance of (innovative) animal models for vaccine development
Moderator: Prof. Niels Hellings, UHasselt
10:00
In search for models predicting clinical success; lessons learned from COVID-19
Dr. Kai Dallmeier, Group Leader Molecular Vaccinology and Vaccine Discovery, KU Leuven, Belgium
10:30
Modelling human cellular immune responses in humanized mice
Prof. Dr. Christian Münz, Viral Immunobiology, Director of the Institute of Experimental Immunology, University of Zurich, Switzerland
11:00
Coffee break
11:30
Pitch session
12:30
Lunch break & Networking
Afternoon Session: Non-animal alternatives for vaccine development
Moderator: Prof. Jo Van Ginderachter, VUB/VIB
14:00
Resolving immunogenic exposures from the gut microbiome in human health and disease –
Implications for vaccine development
Prof. Paul Wilmes, Professor Systems Ecology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
14:30
Update on EPAA projects on vaccines
Dr. Marie-Emmanuelle Behr-Gross, Scientific Programme Manager, European Directorate for the Quality of Medicines and HealthCare (EDQM), Council of Europe
15:00
Challenging Animal Models with Models of Challenges: RSV Finds Pharmacometrics for Leveraging Literature
Dr. Jeffrey Sachs, Distinguished Scientist, PPDM-Quantitative Pharmacology and Pharmacometrics, MSD, US
15:30
Coffee break
16:00
Panel debate: “Successes & challenges in moving forward and beyond animal models in vaccine R&D”
With Dr. Eddy Rommel, Rommel Consulting Partners SRL and Prof. Dr. Joeri Aerts, VUB and Dr. Dirk Jochmans - KU Leuven
16:45
CLOSING KEYNOTE: Advancing translational research using porcine cancer models: current progress and future applications
Dr. Kyle Schachtschneider, Research Assistant Professor, University of Illinois, Chicago, US
17:30
Pitch Award & Closing Word
17:45
Networking Reception
Platinum Sponsor
Disclaimer
Please be aware that at the event location you will need to follow the organizer’s safety policies, as well as local laws and restrictions regarding covid-19.
In the event of a cancellation of the on-site part of Immunity for Health, either government imposed or otherwise, the offer will fall back entirely on the virtual component. On-Site participation tickets will then be automatically converted to online participation tickets. In case the full amount has been already paid, the difference in ticket pricing between the on-site tickets and online tickets will be reimbursed. A cancellation of the on-site event does not equal a cancellation of your participation. Under no circumstance Flanders Vaccine can be held liable for other costs made in the scope of this event, such as transportation or accommodation costs.